hormone

Biden is receiving radiation and hormone therapy to treat his prostate cancer

Former President Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving office, a spokesperson said Saturday.

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone treatment,” Biden aide Kelly Scully said.

Biden, 82, left office in January after he had dropped his bid for reelection six months earlier following a disastrous debate against Republican Donald Trump amid concerns about Biden’s age, health and mental fitness. Trump, despite similar questions during the campaign about his age and mental fitness, defeated Democrat Kamala Harris, who was Biden’s vice president.

In May, Biden’s postpresidential office announced that he had been diagnosed with prostate cancer and that it had spread to his bone. The discovery came after he reported urinary symptoms.

Prostate cancers are graded for aggressiveness using what is known as a Gleason score. The scores range from 6 to 10, with 8, 9 and 10 prostate cancers behaving more aggressively. Biden’s office said his score was 9, suggesting his cancer is among the most aggressive.

Last month, Biden had surgery to remove skin cancer lesions from his forehead.

Superville writes for the Associated Press.

Source link

Children’s Hospital L.A. ends transgender program despite state law

When Children’s Hospital Los Angeles first told thousands of patients it was shuttering its pediatric gender clinic last month, Jesse Thorn was distraught but confident he could quickly find a new local care team for his kids.

But by the time the Center for Transyouth Health and Development officially closed its doors on Tuesday, the father of three was making plans to flee the country.

“They’re targeting whoever they can,” Thorn said. “[I’m afraid] the police will show up at my door because I took my child to see their doctor.”

Until this week, Children’s was among the largest and oldest pediatric gender clinics in the United States — and one of few providing puberty blockers, hormones and surgical procedures for trans youth on public insurance.

The closure of the renowned program signals a wider unraveling in the availability of care across the country, experts said. That includes in former safe havens such as California, New York and Illinois, where state laws protecting trans-specific healthcare are crumbling under mounting legal pressure and bureaucratic arm-twisting by the Trump administration.

In the last week, University of Chicago Medicine and Children’s National in D.C. announced they will end or dramatically scale back services for trans youth, following similar moves by Stanford Medicine, University of Pittsburgh Medical Center and Children’s Hospital of Orange County.

“There’s a rapid collapse of the provision of this care in blue states,” said Alejandra Caraballo, a civil rights attorney and legal instructor at Harvard. “By end of 2025, most care will effectively be banned.”

Some parents in L.A. say they fear the Department of Justice will use private medical data subpoenaed from California’s largest pediatric safety-net hospital to take their children away from them.

“It’s absolutely terrifying,” said Maxine, the mother of a Children’s Hospital patient, who declined to give her last name for fear of attacks on her son.

“I’m very afraid that the DOJ and this acting Attorney General are going to come after parents and use the female genital mutilation law … to prosecute parents and separate me from my child,” she said.

On July 9, Atty. Gen. Pam Bondi announced the Department of Justice was subpoenaing patient medical records from more than 20 doctors and clinics, the latest in a cavalcade of legal and technical maneuvers against providers who care for trans youth.

“Medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable by this Department of Justice,” Bondi said in a news release announcing the move.

Children’s would not say whether it had been subpoenaed or if it had turned over records responsive to the government’s demand.

The Justice Department was already investigating pediatric specialists for a litany of alleged crimes, from deceptive trade practices to billing fraud. Federal health agencies have vowed to withhold funding from institutions that continue to provide affirming care.

“These threats are no longer theoretical,” Children’s Hospital executives wrote to staff in an internal email announcing the closure June 12. “[They are] threatening our ability to serve the hundreds of thousands of patients who depend on CHLA for lifesaving care.”

Advocates say gender-affirming care is also lifesaving. They point to statistics — contested by the federal government and some experts — showing high rates of suicide among trans youth.

In June, the decision to shutter the clinic was widely condemned. Advocates said Children’s Hospital L.A. had “thrown trans kids under the bus” in disregard of state law.

Few are saying that now.

“You could see kids with leukemia being cut off their chemo therapy unless these hospitals stop provide care to trans people,” Caraballo said. “If one of the biggest children’s hospitals in the country couldn’t shoulder that burden, I don’t see many others being able to do so.”

Others agreed.

“No matter what California or any other state has done to say, ‘We want to protect these kids,’ unless they can write checks that equal the amount of money that’s being lost, [programs close],” said Dara E. Purvis, a law professor at Temple University.

So far, the Trump administration has painted parents as victims of “radical gender ideology.”

Some experts warned that as the government tightens the screws on doctors and hospitals, trans teens and their families are likely to seek hormones outside the medical system, including through gray market channels.

“We’ve seen this with abortion,” Caraballo said. “People are going to go about getting it whichever way they can.”

There are fears that families could face prosecution for continuing to seek medications, similar to charges being filed against mothers who have secured abortion pills for their teenagers.

“We’re working with Congress on existing criminal laws related to female genital mutilation to more robustly protect children,” Justice Department Chief of Staff Chad Mizelle said during a Federal Trade Commission workshop entitled “The Dangers of ‘Gender-Affirming Care’ for Minors.”

“We are using all of the tools at the Department of Justice to address this issue,” Mizelle said.

For now, dozens of hospitals across California still provide gender-affirming care, including hormone therapy and surgical procedures.

But the list changes almost day to day.

“Even programs that may have been operating a month ago are not operating now,” said Terra Russell-Slavin, chief impact officer at the Los Angeles LGBT Center. “There’s a lot of concern about even being public about offering care because those agencies become targets.”

With the medical care their children rely on under threat and few promised protections from the state, some families are unsure what the coming months will bring.

For one Orange County father, who asked not to be named for fear of retaliation against his trans son, plans for future travel are suddenly in jeopardy.

He said only about half of his son’s identity documents match his gender, and they’ve been warned not to try to change others.

“He won’t be able to leave the country because he can’t get a matching passport,” the father said.

For Maxine, the L.A. mom, balancing the banal with the existential is a daily strain.

“My kid is just living their life. They want to go to concerts, they want to go shopping for back to school — they don’t know any of this is happening,” the mother said. “You have to experience this intense fear while maintaining a normal household for everybody else.”

Source link

Supreme Court upholds laws that ban hormones for transgender teens

The Supreme Court ruled Wednesday that states may ban hormone treatments for transgender teens, rejecting the claim that such gender-based discrimination is unconstitutional.

In a 6-3 decision, the justices said states are generally free to decide on proper standards of medical care, particularly when health experts are divided.

Chief Justice John G. Roberts, writing for the court, said the state decides on medical regulations. “We leave questions regarding its policy to the people, their elected representatives, and the democratic process,” he said.

In dissent, Justice Sonia Sotomayor said the law “plainly discriminates on the basis of sex… By retreating from meaningful judicial review exactly where it matters most, the Court abandons transgender children and their families to political whims. In sadness, I dissent.” Justices Elena Kagan and Ketanji Brown Jackson agreed.

The ruling upholds laws in Tennessee and 23 other Republican-led states, all of them adopted in the past four years.

Tennessee lawmakers said the number of minors being diagnosed with gender dysphoria had “exploded” in recent years, leading to a “surge in unproven and risky medical interventions for these underage patients.”

California and other Democratic-led states do not prohibit doctors from prescribing puberty blockers or hormones for those under age 18 who are diagnosed with gender dysphoria.

While the court’s ruling in the Tennessee case should not directly affect California’s law, the Trump administration seeks to prevent the use of federal funds to pay for gender affirming care.

This could affect patients who rely on Medicaid and also restrict hospitals and other medical clinics from providing hormones and other medical treatments for minors.

Wednesday’s decision highlights the sharp turn in the past year on trans rights and “gender affirming” care.

Solicitor Gen. Elizabeth Prelogar, representing the Biden administration, had appealed to the Supreme Court in November, 2023, and urged the justices to strike down the red state laws.

She spoke of a broad consensus in favor of gender affirming care. It was unconstitutional, she argued, for states to ban “evidence-based treatments supported by the overwhelming consensus of the medical community.”

But Republican lawmakers voiced doubt about the long-term effect of these hormone treatments for adolescents.

Their skepticism was reinforced by the Cass Report from Britain, which concluded there were not long-term studies or reliable evidence in support of the treatments.

In his first day in office, President Trump issued an executive order condemning “gender ideology extremism.”

He said his administration would “recognize two sexes, male and female. These sexes are not changeable and are grounded in fundamental and incontrovertible reality.”

His administration later said its ban on gender affirming care for minors would extend to medical facilities receiving federal funds.

Source link

Judge rules federal prisons must continue providing hormone therapy to transgender inmates

The federal Bureau of Prisons must continue providing hormone therapy and social accommodations to hundreds of transgender inmates following an executive order signed by President Trump that led to a disruption in medical treatment, a federal judge ruled Tuesday.

U.S. District Judge Royce Lamberth said a federal law prohibits prison officials from arbitrarily depriving inmates of medications and other lifestyle accommodations that its own medical staff has deemed to be appropriate.

The judge said the transgender inmates who sued to block Trump’s executive order are trying to lessen the personal anguish caused by their gender dysphoria, which is the distress that a person feels because their assigned gender and gender identity don’t match.

“In light of the plaintiffs’ largely personal motives for undergoing gender-affirming care, neither the BOP nor the Executive Order provides any serious explanation as to why the treatment modalities covered by the Executive Order or implementing memoranda should be handled differently than any other mental health intervention,” he wrote.

The Bureau of Prisons is providing hormone therapy to more than 600 inmates diagnosed with gender dysphoria. The bureau doesn’t dispute that gender dysphoria can cause severe side effects, including depression, anxiety and suicidal thoughts, the judge said.

The Republican president’s executive order required the bureau to revise its medical care policies so that federal funds aren’t spent “for the purpose of conforming an inmate’s appearance to that of the opposite sex.”

Lamberth’s ruling isn’t limited to the plaintiffs named in the lawsuit. He agreed to certify a class of plaintiffs consisting of anyone who is or will be incarcerated in federal prisons.

Trump’s order also directed the federal Bureau of Prisons to ensure that “males are not detained in women’s prisons.” In February, however, Lamberth agreed to temporarily block prison officials from transferring three incarcerated transgender women to men’s facilities and terminating their access to hormone therapy.

The plaintiffs are represented by attorneys from the Transgender Law Center and the American Civil Liberties Union.

Lamberth, a senior judge, was nominated to the bench by President Ronald Reagan in 1987.

Kunzelman writes for the Associated Press.

Source link